Round Rock Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
5,303
-544
-9% -$202K 0.26% 57
2026
Q1
$1.71M Sell
5,847
-584
-9% -$192K 0.26% 53
2025
Q4
$2.25M Hold
6,431
0.34% 40
2025
Q3
$2.08M Sell
6,431
-375
-6% -$117K 0.33% 42
2025
Q2
$2.65M Sell
6,806
-9
-0.1% -$3.62K 0.46% 42
2025
Q1
$2.96M Sell
6,815
-483
-7% -$194K 0.55% 35
2024
Q4
$2.77M Buy
7,298
+89
+1% +$37.2K 0.57% 35
2024
Q3
$3.74M Hold
7,209
0.87% 23
2024
Q2
$3.91M Buy
7,209
+309
+4% +$163K 0.95% 21
2024
Q1
$3.58M Sell
6,900
-1,674
-20% -$833K 0.86% 24
2023
Q4
$4.04M Buy
+8,574
New +$3.96M 1.02% 20

Other funds holding ELV

Round Rock Advisors's ELV Position: Q2 2026 in Review

Round Rock Advisors reduced its Elevance Health (ELV) stake by 9.3% in Q2 2026, selling an estimated $202K and leaving 5,303 shares worth $2.05M. The position accounts for 0.26% of the portfolio, ranked #57.

Round Rock Advisors first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.04M in Q4 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Round Rock Advisors held 5,303 shares of Elevance Health worth $2.05M as of Q2 2026.
  • Round Rock Advisors sold 544 Elevance Health shares in Q2 2026, an estimated $202K.
  • Elevance Health made up 0.26% of Round Rock Advisors's portfolio in Q2 2026, its #57 holding.
  • Round Rock Advisors first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Round Rock Advisors's Elevance Health position peaked at $4.04M in Q4 2023.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.